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Abstract. – OBJECTIVE: The limitation of alter-

native transfusion practices in infants increases
the benefits of blood conservation. We analyzed
the efficacy of a structured program to reduce
transfusions and transfusion-associated complications in cardiac surgery
PATIENTS AND METHODS: Our pediatric surgery database was reviewed retrospectively, comparing outcomes from two different time periods,
after the implementation of an effective blood conservation program beginning in March 2014. A total of 214 infants (8.1±3.4 months) who underwent
biventricular repair utilizing CPB (Group 1 – Blood
conservation) were studied in a 12-month period
(March 2014-February 2015) after the implementation of the new program, and compared with 250
infants (7.91±3.2 months) (Group 2 – Control-No
blood conservation) of the previous 12 – month period (March 2013-February 2014).
RESULTS: The proportion of patients transfused with red blood cells was 75.2% (N=188) in
control group and reduced by 16.4% in the study
group (58.8% – 126 patients, p <0.01). The mean
number of transfusions was 1.25 ± 0.5 units per
patient in control group and decreased to 0.7 ±
0.5 units per patient after the start of the program (p = 0.035). Cerebral oximetry demonstrated better follow-up during the operative period
confirming less hemodilution in Group 1. Respiratory support, inotropic need and ICU stay were
significantly better in the study group.
CONCLUSIONS: These findings, in addition to
attendant risks and side effects of blood transfusion and the rising cost of safer blood products, justify blood conservation in pediatric
cardiac operations. Circuit miniaturization, ultrafiltration, and reduced postoperative bleeding, presumably secondary to higher fibrinogen
and other coagulation factor levels, contributed
to this outcome.
Key Words:
Are Blood management, Conservation, Consequences, Pediatric, Cardiopulmonary bypass, CPB (setups, equipment, Surface coatings, etc.).
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Introduction
Surgery for congenital heart defects in pediatric patients undergoing cardiopulmonary bypass
(CPB) has induced up to a 300% hemodilutional
effect due to circuit prime volumes1. Condensing
surface area and prime volume are especially
important in neonatal patients where the volume
from the CPB circuit can be the major determinant in the patient’s metabolic response to surgery2. This is due not only to the profound difference in the patient’s size with respect to the
CPB prime volume but also from the deleterious
effects of CPB on their immature organ function3.
Additionally, hemodilution effect due to prime
volume can result in multiple blood product exposures, all of which have been shown to further
increase the morbidity of CPB4,5. Thus, attempts
to condense the circuit prime volume can result
in a reduction of exposure to blood products6.
Despite the recent introduction of a number of
technical and pharmacologic blood conservation
measures, bleeding and allogeneic transfusion
remain persistent problems in open-heart surgical procedures.The use of blood products carries
several risks, such as immunologic sensitization,
anaphylactic reaction, and disease transmission.
The underlying pathophysiology has not been described entirely; however, there is evidence on the
activation of inflammatory genes and cytokines
in circulating leukocytes with transfusion of red
blood cells7. Efforts should be made to decrease
or completely avoid transfusions to avoid these
negative reactions.
In an effort to reduce the negative impact of the
CPB on the adult population outcome, the minimized systems were developed to significantly reduce
the hemodilution of the patient and reduce the foreign surface area that comes in continuous contact
with the patient circulating blood volume. Redu-
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cing the size of the perfusion apparatus has two
obvious and immediate effects: firstly, a reduction
in the contact surface area for potential blood-biomaterial contact; secondly, a reduction in priming
volume requirement-less hemodilution with a consequential reduction in perioperative hematocrit8.
This concept later targeted pediatric population. Smaller, lower prime-volume circuits are
now available with low line pressures and excellent reliability and it is now possible to review the
basic need for hemodilution and hypothermia9.
There is wide variation in the prevalence of perioperative transfusions in cardiac surgery. The large
differences between institutions cannot be explained just by differences in patient characteristics.
Most likely, institutional and individual differences
in transfusion practice, guidelines and attitudes influence the frequency and number of transfusions.
The decision to transfuse is based on multiple
patient factors and it is impossible to designate a
single transfusion trigger. The high prevalence initiated a multifactorial blood conservation program
with the intention of reducing transfusions without
compromising patient safety10.
The aim of this retrospective study was to evaluate the efficacy of a structured program to reduce transfusions and transfusion-associated complications in pediatric cardiac surgery.

Patients and Methods
After institutional Review Board approval
(14/227) in tertiary pediatric cardiac centers, the
database was reviewed retrospectively, comparing outcomes from two different one-year periods with and without blood conservation strategy.
A total of 214 infants (8.1±3.4 months) who
underwent biventricular repair utilizing cardiopulmonary bypass (CPB) (Group 1 – Blood
conservation) were studied in a 12-month period (March 2014-February 2015) after the implementation of the new program, and compared
with 250 infants (7.91±3.2 months) (Group 2 –
Control-No blood conservation) of the previous
12-month period (March 2013-February 2014).
The outcome (dependent variable) was stated as
blood transfusion. Independent variables were
identified. None of the patients were premature.
Exclusion criteria consisted of known coagulopathy and endocarditis. The remainder of the patients who did not have the exclusion criteria was
included in the study.

Pathologies in group 1 were: VSD repair in 88,
cavo-pulmonary anastomosis in 46, aortic valvotomy in 17, arterial switch+VSD repair in 9, arterial
switch in 44, TAPVR repair in 10 patients. Pathologies in group 2 were: VSD repair in 104, AVSD
repair in 5, atrial septectomy+shunt in 16, cavo-pulmonary anastomosis in 95, arterial switch+VSD repair in 8, TAPVR repair in 7, AP window in 9, truncus repair in 3 and Senning operation in 3 patients.
The blood conservation program was designed
as follows:
• Education: All the staff involved in the care of
the patients, including surgeons, anesthetists,
residents, OR-, ICU- and ward nurses, nurse helpers, physiotherapists and perfusionists
were educated about the risks and benefits of
blood transfusions and the new transfusion
guidelines in a 45-min lesson. The lesson was
repeated for all new employees.
• Guidelines: we revised our guidelines for
transfusions based on the Society of Thoracic Surgeons Guidelines11. In the institutional
guidelines, the decision to transfuse red cells perioperatively should be based on clinical
judgment of the patient’s clinical and hemodynamic status. Patients received red blood
cell when a hematocrit level of < 20%, mixed
venous oxygen saturation < 60% and regional
cerebral oxygenation (rSO2) < 50%. The final
decision to transfuse or not was always at the
discretion of the physician responsible.
• Transfusion log: a specific transfusion log was
added to the patient records. In this log, all
transfusion episodes were registered together
with time of transfusion, indication for transfusion, type of blood product, amount (units),
patient status including blood pressure, pulse,
mixed venous oxygenation, hematocrit levels
and the prescribing physician.
• Reduction in IV fluid volume: we initiated a
series of measures aimed at reducing hemodilution volume. All sources and volumes of IV
fluid were obtained from the medical record.
• CPB Circuit Design: significantly less prime
volume via oxygenator with integrated arterial
filter, condensed circuit, pole mounted vents, microplegia, ultrafiltration, use of cerebral oxymetry-rSO2, retrograde autologous priming, vacuum
assisted venous drainage and cell salvage of the
residual blood from the circuit without treatment
Operative Technique
As a part of the blood conservation program,
the bypass circuit was aseptically assembled using
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a low-prime integrated oxygenator and reservoir
(Terumo Medical Corporation, Ann Arbor, MI,
USA) in Group 1 and a Terumo System 1 pump
console. All of the roller heads of the pump were
remotely mounted to minimize tubing length and
circuit surface area.Isothermic blood cardioplegia
was administered directly into the aorta at the surgical field using premixed syringes of a 1:4 hyperkalemic solution (1 part blood: 4 parts crystalloid)
(Pharmedium, Portland, OR, USA). The static prime volume for the circuit was approximately 220
ml. The pump prime consisted of the following
additives:
(Total 95-110 cc): 1 mg/kg (100 unit/kg) heparin, 20 mg/kg cefamezin, 2.5 cc/kg, 20% mannitol, 10 mEq sodium bicarbonate, plasmalyte, red
blood cell and fresh frozen plasma estimated at
target hematocrit 25-30%.
As part of our previous routine, control group
consisted of a conventional oxygenator and reservoir (Sorin, Arvada, CO, USA) that has a static
priming volume of 350 cc.
The pump prime for control circuits consisted
of the following additives:
(Total 200-215 cc): 1 mg/kg (100 unit/kg) heparin, 20 mg/kg Cefamezin, 2.5 cc/kg, 20% mannitol, 10 mEq sodium bicarbonate, plasmalyte , red
blood cell and fresh frozen plasma estimated at
target hematocrit 25-30%.
Anticoagulation status was monitored using
the Medtronic HMS+ (Medtronic, Minneapolis, MN, USA) system. Samples of blood for
measuring activated clotting times (ACT) and
heparin concentrations were drawn every 30
minutes on CPB. Adequate anticoagulation was
defined as ACT greater than 500 seconds and
heparin concentration assays greater than or
equal to 3.0 mg/kg, as measured by the HMS+
device. Midazolam, sevoflurane, fentanyl and
norcuronium were used as anesthetic agents.
After median sternotomy, the patient was systemically anticoagulated using 339 units/kg of intravenous heparin. The pulse pressure was verified,
retrograde autologous priming (RAP) was initiated, and approximately 75-85 ml of crystalloid
prime was removed. During the RAP sequence,
venous cannulas (Edwards Lifesciences, Irvine,
CA, USA) were placed in the superior vena cava
and inferior vena cava, respectively.
Vacuum-assisted venous drainage was utilized
to allow for the use of the smaller venous cannula and venous circuit. Upon initiation of bypass,
crystalloid in the venous line was diverted into
a collection bag and discarded. Full flow to the
1076

patient was achieved with no hemodynamic instability within five minutes of aortic cannulation.
CPB flow was maintained at 125-150 mL/kg/
minute. Moderate hypothermia (28-34°C) and alpha stat blood gas management were used.
After the repair, heart was aggressively de-aired. The aortic cross-clamp was removed and
the patient was systemically rewarmed to normothermia. A second blood gas was drawn to
ensure proper electrolyte balance prior to termination of CPB support. The resultant hematocrit
was around 20%. Continuous ultrafiltration was
performed while the patient was on CPB and approximately a total of 80-90 ml of plasma water
was removed.
Circuit integrity was maintained until the patient was transported to the pediatric intensive
care unit.
Perioperative Follow-up
For each patient, the following factors were
evaluated before discharge and documented:
Hemodynamic parameters, perfusion and cross
clamp duration, intubation period, postoperative
hemorrhage, use of blood (as units) during the
hospital stay, use of inotropic support, complications and infection, the duration of ICU stay and
hospital stay, perioperative mortality.Comparison
between groups was performed retrospectively.
Blood Samples and Assays
Complete blood count [hemoglobin, hematocrit,
erythrocyte, white blood cell (WBC) and platelet
counts] was recorded. Results of standard blood
and urine chemistry were documented. Blood samples were collected in potassium-EDTA (ethylene
di-amine-tetra acetic acid) tubes using a radial or
femoral artery catheter at the following intervals:
• Baseline: After induction of anesthesia (T1)
• OFF- CPB: 15 min. after reversal with protamine (T2)
• ICU: 24 h postoperatively (T3)
Statistical Analysis
Data was expressed as the mean ± the standard
error of the mean. Analysis of variance for comparison of parameters with a normal distribution
and Mann Whitney U test for comparison of parameters without normal distribution were used.
Univariate analysis was performed on a large
number of preoperative and intraoperative variables in our database to identify those variables
that might be associated with allogeneic blood 6 of
the variables with a higher p-value were retained
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for subsequent analysis.They were entered into a
stepwise multiple logistic regression analysis to
select the ones that were significant independent
predictors of the need for transfusion. Data were
analyzed using SPSS program (Inc. Chicago, IL,
USA). p < 0.05 was considered statistically significant.

Results
The time interval between birth and operative repair was not significantly different in both
groups. There was not any significant difference
with respect to age, gender, height, weight and
body surface area between groups.
Preoperative physical and laboratory evaluation
revealed no difference among patient groups. List
of variables that were screened for possible association with transfusion (dependent variable: transfused allogeneic blood) and significant predictors
of allogeneic transfusions was listed in Table I.
There was a significant decrease in transfusions
when the program was started. The proportion of
patients transfused with red blood cells was 75.2%
(N=188) in control group and reduced by 16.4% in
the study group (58.8% – 126 patients, p = 0.0089).
The mean number of transfusions was 1.25 ± 0.5
units per patient in control group and decreased
to 0.7 ± 0.5 units per patient after the start of the
program (p = 0.035).
Cerebral oximetry demonstrated significantly
better follow-up during the operative period confirming less hemodilution in Group 1. Respiratory
support duration, inotropic need and IUCU stay
were significantly better in blood conservation
group.Perioperative data is summarized in Table II.
No mortality occurred in Group 1; however,
two patients needed prolonged respiratory support for pneumonia and one required the implantation of a permanent pacemaker. Mortality
was two patients in Group 2 due to pulmonary
hypertension. Moreover, two patients in this

group needed prolonged respiratory support for
pneumonia and one had a permanent pacemaker
implanted.

Discussion

Blood administration is never without the risk
for patients. As such, it is desirable to attempt
to reduce or eliminate allogeneic blood product
transfusions. More families and patients are becoming aware of the long and short-term risks associated with the administration of blood and are
asking for bloodless techniques even if it is not a
religious preference.
Blood conservation has become popular following STS Guidelines but focused on adult cardiac surgery. Ferraris et al12 on 2011 update noted
the statement “for almost all topics reviewed only
evidence relating to adult patients entered into the
final recommendations, primarily because of limited availability of high quality evidence relating
to pediatric patients having cardiac procedures”.
Jonas13 later commented by underlining related
studies on pediatric population. In 2008 Wypij et
al14 published the combined results of 2 prospective
randomized trials of hematocrit levels during CPB
in infants. The authors concluded that a hematocrit
level of approximately 24% or higher during CPB
was associated with higher psychomotor development index scores at 1 year of age and reduced
lactate levels intraoperatively. Lower hematocrit
levels were also associated with more positive intraoperative fluid balance. These 2 large National
Institutes of Health–supported trials also demonstrated that a goal hematocrit level of either 30%
or 35% could be achieved during bypass without
greater need for transfusion relative to the standard
hematocrit level of 20% that was previously applied widely for pediatric CPB before these trials.
Circuit miniaturization, ultrafiltration, and reduced postoperative bleeding, presumably secondary
to higher fibrinogen and other coagulation factor
levels, contributed to this outcome14, 15.

Table I. Significant Predictors of Alllogeneic Transfusions.
Rısk factors

Odds
Ratio

Confidence
interval

Multıvarıate
p-value

Lower Body Surface Area
Lower Preoperative Hematocrit
Lower Red Blood Cell Mass
Increased Total Crystalloid Volume
Conventional Circuit Size
Increased Postoperative bleeding in 24 h

3.160
4.3
1.1
4.1
5.8
3.7

1.300-10.3
1.300-9.500
0.950-0.970
1.2-12.5
1.190-20.540
1.250-9.150

0.006
0.003
0.056
0.035
0.021
0.005
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Table II. Perioperative evaluation of patients.

Duration of CPB (min)
Duration of x-clamp (min)
rSO2 desaturation risk>6000 (yes or no) (%)
t-intub (h)
Postop hemorrhage (mL)
Blood transfusion (Unit)
Inotropic support (n)
ICU stay (day)
Hospital stay (day)
Mortality (n)

Group 1
(Blood Conservation)

Group 2
(Control)

p

120.4±56
84.4±26
15.8±9*
11.4±7*
145±50
0.7±0.5*
69(32%)*
3.2±1.1*
10.4±3
-

122±39
92.2±27
27.8±11
19.8±8
175±55
1.25±0.5
149(59.6%)
5.9±1.2
15.5±4
2

=0.75
=0.24
=0.038
=0.041
=0.16
=0.035
=0.014
=0.045
=0.055
=0.24

Tx: Transfusion; CPB: Cardiopulmonary bypass; X-clamp: Aortic cross clamp; t-intub: respiratory support time; ICU: Intensive
care uni; rSO2: Regional cerebral O2 saturation

Ootaki et al16, in a prospective, non-continuous
study of 75 pediatric patients undergoing cardiac
surgery using a criteria-driven transfusion protocol, achieved 70% transfusion free procedures.
Mean weight of the transfusion free group was
24.6 ± 13.4 kg.
We tried to implement a simple blood conservation program including education, introduction
of guidelines, follow-up of transfusions and restrictions on fluid balance. We made every possible effort intraoperatively by using CPB-related
techniques to avoid hemodilution.
CPB exerts intended and unintended effects
on the enzymatic and formed elements of the
coagulation system. Compared with adults,
children are at special risk for known, and
unknown, differences in their hemostatic systems. Although children have relatively larger circulating blood volumes when compared
with adults, their low absolute blood volume
accentuates their dilutional coagulopathy.
Further, their small blood volume creates
practical limitations on the use of certain blood conservation strategies such as autologous
donation and cell saver17.
Changes in oxygenator and CPB pump system
design in the last 5 years and their introduction
to the clinical arena have enabled significant reductions in priming volume in pediatric bypass
circuits. The pediatric population, excluding neonates, provides the challenge of deciding whether a
bloodless prime can be used for a specific patient.
One of the greatest benefits of the low prime
condensed circuits is in the reduction of CPB prime by eliminating an external arterial line filter
and the associated filter bypass loop and extra tubing needed to encompass the use of an arterial
1078

line filter. The elimination of an external arterial
filter has not only reduced the overall CPB surface area but has also allowed us to decrease our
overall prime volumes. This has been accomplished through a reduction in static prime volume
and also by allowing placement of the oxygenator
closer to the patient6.
Our paper is a retrospective study and this is
one of the main limitations of the data.We accept
this data as preliminary to build a strategy and
started a newer protocol and assessment based
on current outcomes obtained from retrospective
evaluation.
In our series of blood conservation patients,
we were able to achieve 41.2% of them (88/214)
transfusion free procedures compared to 24.8
(62/250) in control.
We studied through variables related to preoperative and intraoperative period and demonstrated
that the most significant risk factors for transfusion were body surface area (OR: 3.16), preoperative hematocrit (OR: 4.3), red blood cell mass
(OR: 1.1), total crystalloid volume (OR: 4.1), conventional circuit (OR: 5.8), postoperative bleeding
in 24 h (OR: 3.7). The results of the present study
demonstrate that a structured blood conservation
program reduces transfusion prevalence and this
can be achieved without compromising patient
safety.
The large variability in children, cardiac pathology and surgical techniques has made large,
randomized, clinical trials hard to conduct and
difficult to analyze. Consequently, much practice
has evolved from the application of animal data
and shared experience. Currently, there is a lack
of quality randomized, prospective clinical trials
to support evidence-based practice. In order to
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continue to improve surgical outcomes, we must
continue to ask the correct questions and attempt
to answer them with the appropriate researches.
Our patient population is small. That may be a
reason not to get clear significant differences in
most of the clinical parameters.

Conclusions
We may say that there is incomplete evidence
regarding to the transfusion decisions during pediatric CPB. Our findings confirm that transfusion of red blood cells during CPB may cause an
undesirable clinical outcome. It is clear that blood management with multiple strategies is valid
for pediatric population. Hemodilution becomes
more important in lower body surface area. We
believe novel CPB technologies may be contributory in blood management strategies regarding
pediatric patients undergoing open-heart surgery.
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